Scilex Holding (SCLXW) Long-Term Investments (2021 - 2026)

Scilex Holding (SCLXW) recorded quarterly Long-Term Investments of $4.8 million in Q1 2026, down 96.97% quarter-over-quarter from $159.4 million in Q4 2025, and down 93.89% on a YoY basis from $79.1 million in Q1 2025.

Scilex Holding (SCLXW) Long-Term Investments (2021 - 2026) Analysis & Trends

Scilex Holding's Long-Term Investments history runs 5 years deep, the most recent figure standing at $4.8 million for Q1 2026.

  • In Q1 2026, Long-Term Investments fell 93.89% year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $4.8 million (down 93.89% YoY), while the FY2025 annual figure was $159.4 million, changed N/A from the prior year.
  • Long-Term Investments was $4.8 million for Q1 2026 at Scilex Holding, down from $159.4 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $159.4 million in Q4 2025 to a low of $2.4 million in Q3 2024.
  • Historically, Long-Term Investments has averaged $72.0 million across 4 years, with a median of $79.1 million in 2025.
  • The sharpest annual moves came in 2022 and 2026: Long-Term Investments soared 90030473.08% in 2022, then tumbled 93.89% in 2026.
  • A 4-year view of Long-Term Investments shows it stood at $101.3 million in 2022, then tumbled by 97.66% to $2.4 million in 2024, then surged by 6611.71% to $159.4 million in 2025, then tumbled by 96.97% to $4.8 million in 2026.
  • The last three Long-Term Investments figures came in at $4.8 million (Q1 2026), $159.4 million (Q4 2025), and $16.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 133.47 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 3.12 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn -
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 268.00 Mn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 1.11 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 983.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 1.63 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 366.00 Mn
10 Scilex Holding - - 4.15 Mn 4.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.83 Mn
Dec 31, 2025 159.40 Mn
Sep 30, 2025 16.35 Mn
Jun 30, 2025 2.47 Mn
Mar 31, 2025 79.10 Mn
Sep 30, 2024 2.38 Mn
Sep 30, 2022 101.29 Mn
Jun 30, 2022 141.59 Mn
Mar 31, 2022 140.45 Mn
Dec 31, 2021 139.41 Mn
Sep 30, 2021 139.41 Mn
Jun 30, 2021 139.41 Mn
Mar 31, 2021 156.00